Oral Presentation

[28M-pm] Immune system and biological defense-2

Mon. Mar 28, 2022 2:30 PM - 3:30 PM [Room M] Conference Room 232 (Bldg. 2: 3F)

Chair: Hiroto Kawashima

+Add all to schedule

2:30 PM - 2:42 PM

[28M-pm06S] Intratumor administration of a highly active form of XCL1 using a hydrophilic gel patch induced antitumor effect through accumulation of XCR1+dendritic cells and improvement of tumor microenvironment

○Yusuke Yoshida¹, Momo Kamei¹, Kazuhiko Matsuo¹, Mayuko Otsuki¹, Yuta Hara¹, Ying-Shu Quan², Fumio Kamiyama², Takashi Nakayama¹ (1. Division of Chemotherapy, Kindai University Faculty of Pharmacy, 2. CosMED Pharmaceuticals. Co., Ltd. )

2:42 PM - 2:54 PM

[28M-pm07S] Bmal1 regulate browning of white adipocyte in mice

○Hirotake ishii¹, Satoshi Kitaura¹, Yukiko Takasugi¹, Taira Wada¹, Shigeki Shimba¹ (1. Sch. Pharm., Nihon Univ.)

2:54 PM - 3:06 PM

[28M-pm08S] Adipocyte-specific GLS1 knockout abrogates high fat diet-induced obesity in mice.

○Yudai Machida¹, Kazutaka Akagi³, Keiichi Koizumi^1,2 (1. Grad.Sch.pharm.Sci.,Toyama Univ, 2. Inst. Nat. Med., Univ. of Toyama, 3. Res. Cent. Pre-dis. Sci., Univ. of Toyama)

3:06 PM - 3:18 PM

[28M-pm09] Deletion of AhR prevents liver fibrosis in non-alcoholic steatohepatitis (NASH).

○Taira Wada¹, Akinori Sakai¹, Mayu Tanabe¹, Hirotake Ishii¹, Yukiko Takasugi¹, Shigeki Shimba¹ (1. Sch. of Pharm. Nihon Univ.)

3:18 PM - 3:30 PM

[28M-pm10S] A nanaomycin derivative suppresses imiquimod-induced psoriasis

○Yudai Matsui¹, Naoki Takemura², Manabu Taura², Tatsuya Saitoh² (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ.)

Session information